These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 34297878)

  • 1. Operational challenges in the COVID-19 era: Asymptomatic infections and vaccination timing.
    Axelrod DA; Ince D; Harhay MN; Mannon RB; Alhamad T; Cooper M; Josephson MA; Caliskan Y; Sharfuddin A; Kumar V; Guenette A; Schnitzler MA; Ainapurapu S; Lentine KL
    Clin Transplant; 2021 Nov; 35(11):e14437. PubMed ID: 34297878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 vaccination timing and kidney transplant waitlist management: An international perspective.
    Caliskan Y; Axelrod D; Guenette A; Lam NN; Kute V; Alhamad T; Schnitzler MA; Lentine KL
    Transpl Infect Dis; 2022 Feb; 24(1):e13763. PubMed ID: 34796585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International Practices on COVID-19 Vaccine Mandates for Transplant Candidates.
    Caliskan Y; Hippen BE; Axelrod DA; Schnitzler M; Maher K; Alhamad T; Lam NN; Anwar S; Kute V; Lentine KL
    Kidney360; 2022 Oct; 3(10):1754-1762. PubMed ID: 36514724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term kidney transplant outcomes from severe acute respiratory syndrome coronavirus 2 lower respiratory tract positive donors.
    Sanchez-Vivaldi JA; Patel MS; Shah JA; Wang BK; Salcedo-Betancourt JD; Hwang CS; Wojciechowski D; La Hoz RM; Vagefi PA
    Transpl Infect Dis; 2022 Aug; 24(4):e13890. PubMed ID: 35751890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care Workers.
    Angel Y; Spitzer A; Henig O; Saiag E; Sprecher E; Padova H; Ben-Ami R
    JAMA; 2021 Jun; 325(24):2457-2465. PubMed ID: 33956048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transmission and Infectious SARS-CoV-2 Shedding Kinetics in Vaccinated and Unvaccinated Individuals.
    Jung J; Kim JY; Park H; Park S; Lim JS; Lim SY; Bae S; Lim YJ; Kim EO; Kim J; Park MS; Kim SH
    JAMA Netw Open; 2022 May; 5(5):e2213606. PubMed ID: 35608859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survey of current transplant center practices regarding COVID-19 vaccine mandates in the United States.
    Hippen BE; Axelrod DA; Maher K; Li R; Kumar D; Caliskan Y; Alhamad T; Schnitzler M; Lentine KL
    Am J Transplant; 2022 Jun; 22(6):1705-1713. PubMed ID: 35143100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solid Organ Transplantation in SARS-CoV-2 Recovered Transplant Candidates: a Comprehensive Review of Recent Literature.
    Kute V; Meshram HS; Fleetwood VA; Chauhan S; Lentine KL
    Curr Transplant Rep; 2022; 9(2):95-107. PubMed ID: 35284204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perspectives on COVID-19 vaccination among kidney and pancreas transplant recipients living in New York City.
    Tsapepas D; Husain SA; King KL; Burgos Y; Cohen DJ; Mohan S
    Am J Health Syst Pharm; 2021 Nov; 78(22):2040-2045. PubMed ID: 34185824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 Infections and Hospitalizations Among Persons Aged ≥16 Years, by Vaccination Status - Los Angeles County, California, May 1-July 25, 2021.
    Griffin JB; Haddix M; Danza P; Fisher R; Koo TH; Traub E; Gounder P; Jarashow C; Balter S
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1170-1176. PubMed ID: 34437525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acceptance of SARS-CoV-2 vaccines by liver transplant recipients and candidates.
    Reuken PA; Albers S; Rauchfuss F; Strnad P; Settmacher U; Trautwein C; Stallmach A; Bruns T
    Z Gastroenterol; 2021 Dec; 59(12):1288-1296. PubMed ID: 34670294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Influence of SARS-CoV-2 vaccination on the epidemiological and clinical characteristics of imported COVID-19 cases in Chengdu].
    Yue Y; Liang X; Mao Y; Hu M; Han DL; Su LY; Chen H; Fan SF; Zhang XC; Yang F; Yuan QW; Liu Z
    Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Aug; 42(8):1365-1370. PubMed ID: 34814555
    [No Abstract]   [Full Text] [Related]  

  • 13. [Humoral immunity against SARS-CoV-2 in workers of social health care centers of Castilla y León after vaccination with the BNT162b2 mRNA vaccine from Pfizer/Biontech.].
    Casas Fischer R
    Rev Esp Salud Publica; 2021 Oct; 95():. PubMed ID: 34690347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practicing With Uncertainty: Kidney Transplantation During the COVID-19 Pandemic.
    Lentine KL; Mannon RB; Josephson MA
    Am J Kidney Dis; 2021 May; 77(5):777-785. PubMed ID: 33388404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 Virus-Like Particle Neutralizing Capacity in Blood Donors Depends on Serological Profile and Donor-Declared SARS-CoV-2 Vaccination History.
    Drews SJ; Hu Q; Samson R; Abe KT; Rathod B; Colwill K; Gingras AC; Yi QL; O'Brien SF
    Microbiol Spectr; 2022 Feb; 10(1):e0226221. PubMed ID: 35171006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An outbreak of SARS-CoV-2 on a transplant unit in the early vaccination era.
    Roberts SC; Foppiano Palacios C; Grubaugh ND; Alpert T; Ott IM; Breban MI; ; Martinello RA; Smith C; Davis MW; Mcmanus D; Tirmizi S; Topal JE; Azar MM; Malinis M
    Transpl Infect Dis; 2022 Apr; 24(2):e13782. PubMed ID: 34969164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virus shedding dynamics in asymptomatic and mildly symptomatic patients infected with SARS-CoV-2.
    Li W; Su YY; Zhi SS; Huang J; Zhuang CL; Bai WZ; Wan Y; Meng XR; Zhang L; Zhou YB; Luo YY; Ge SX; Chen YK; Ma Y
    Clin Microbiol Infect; 2020 Nov; 26(11):1556.e1-1556.e6. PubMed ID: 32653662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breakthrough COVID-19 after SARS-CoV-2 vaccination in solid organ transplant recipients: An analysis of symptomatic cases and monoclonal antibody therapy.
    Yetmar ZA; Bhaimia E; Bierle DM; Ganesh R; Razonable RR
    Transpl Infect Dis; 2022 Apr; 24(2):e13779. PubMed ID: 34932874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transplantation programs facing lack of empirical evidence on SARS-CoV-2 vaccination: A society recommendation consensus update.
    Nevermann N; Wiering L; Wu H; Moroder P; Brandl A; Globke B; Krenzien F; Raschzok N; Schöning W; Lurje G; Öllinger R; Schmelzle M; Pratschke J; Ritschl PV
    Transpl Infect Dis; 2021 Aug; 23(4):e13696. PubMed ID: 34288294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.